Research & Development



  甦煥坐在地上,貪婪的看著頭頂上的大太陽,看的雙眼流淚這才對雲瑯道︰“我姐呢?”   霍光安排好家事之後,就回到父親身邊輕聲道︰“倉庫準備好了,就等雨停之後,好收割糜子。”青娱乐最新官网在线看   一場極為熱鬧的葬禮也落下了帷幕。超碰视频   霍光的哭聲極為低沉,極為壓抑,並沒有傳出很遠,那些跟在雲氏馬車後邊的馬車見他們沒有挪動的意思,就紛紛掉轉車頭,走別的城門了。   甦稚愣了一下,就把已經喝奶喝的開始吐奶的雲動給了丈夫,接過雲樂繼續哺乳。超碰在公开线视频免费   雲瑯沒有走雲氏與長門宮相連的那道門,而是安步當車的從長門宮大門走出來,繞了很遠的路從雲氏大門回來了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo